#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA653704	F	Optimal dose required to inhibit human pancreatic Capan 1 tumor growth after subcutaneous transplantation on athymic mice at 10 mg/kg (treatment schedule: q7dX3)	Homo sapiens	1		organism-based format	Scientific Literature
2.	ALA653705	F	Percentage tumor growth inhibition was calculated in respect to controls one week after the end of the treatment	Homo sapiens	1		cell-based format	Scientific Literature
3.	ALA656157	F	Cytotoxic activity against Capan-1 pancreatic carcinoma tumor cell lines.	Homo sapiens	1		cell-based format	Scientific Literature
4.	ALA656158	F	Cytotoxicity of compound was tested against Capan-1 cell line (pancreatic carcinoma) after incubation for 24 hour	Homo sapiens	2		cell-based format	Scientific Literature
5.	ALA656159	F	Cytotoxicity of compound was tested against Capan-1 cell line (pancreatic carcinoma) after incubation for 72 hour	Homo sapiens	1		cell-based format	Scientific Literature
6.	ALA656320	F	Cytotoxicity of compound was tested against Capen-1 cell line (pancreatic carcinoma) after incubation for 72 hour	Homo sapiens	1		cell-based format	Scientific Literature
7.	ALA656321	F	Compound tested for cytotoxic Activity against Capan-l cell line from pancreatic carcinoma	Homo sapiens	4		cell-based format	Scientific Literature
8.	ALA869983	F	Activity against BRCA2-deficient cells	Homo sapiens	1		cell-based format	Scientific Literature
9.	ALA1952613	A	Antiproliferative activity against human Capan1 cells assessed as cell growth inhibition	Homo sapiens	2		cell-based format	Scientific Literature
10.	ALA902490	F	Inhibition of carbohydrate-dependent galectin1 binding to human Capan1 cell surface at 2mM	Homo sapiens	2		cell-based format	Scientific Literature
11.	ALA967657	F	Cytotoxicity against human Capan1 cells assessed as fraction of viable cells after 72 hrs relative to control	Homo sapiens	13		cell-based format	Scientific Literature
12.	ALA1068305	F	Cytotoxicity against human Capan1 cells after 96 hrs by WST8 assay	Homo sapiens	1		cell-based format	Scientific Literature
13.	ALA1065569	F	Antiproliferative activity against human Capan1 cells after hrs by ATP content assay	Homo sapiens	4		cell-based format	Scientific Literature
14.	ALA1116326	F	Antiproliferative activity against human Capan1 cells expressing BRCA2 6174delT mutation and loss of wild-type allele after 13 days by cell titer-blue assay	Homo sapiens	1		cell-based format	Scientific Literature
15.	ALA2327201	F	Antitumor activity against human Capan1 cells injected into BALB/cAJcl-nu-nu mouse assessed as reduction in tumor weight at 50 ug for 6 days in a week upto 28th days treatment started on 15th day tumor injection	Homo sapiens	2		cell-based format	Scientific Literature
16.	ALA2338925	A	Cytotoxicity against human Capan1 cells after 72 hrs by crystal violet staining method	Homo sapiens	7		cell-based format	Scientific Literature
17.	ALA2363833	F	SANGER: Inhibition of human CAPAN-1 cell growth in a cell viability assay.	Homo sapiens	98		cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
18.	ALA2439462	F	Potentiation of conatumumab-induced apoptosis in human Capan1 cells at 2.5 uM after 5 days by MTS assay	Homo sapiens	2		cell-based format	Scientific Literature
19.	ALA3626085	F	Induction of DNA damage in human BRCA2-deficient Capan1 cells assessed as increase in gammaH2AX levels at 100 uM after 24 hrs by confocal microscopy	Homo sapiens	1		cell-based format	Scientific Literature
20.	ALA3626086	F	Induction of DNA damage in human BRCA2-deficient Capan1 cells assessed as increase in gammaH2AX levels at 8 uM after 24 hrs by confocal microscopy	Homo sapiens	1		cell-based format	Scientific Literature